Esthesioneuroblastoma: A Danish clinicopathelogical study of 40 consecutive cases

被引:25
作者
Ingeholm, P
Theilgaard, SA
Buchwald, C
Hansen, HS
Francis, D
机构
[1] Copenhagen Univ Hosp, Rigshosp, Dept Pathol, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Rigshosp, Dept Otolaryngol Head & Neck Surg, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark
关键词
olfactory neuroblastoma; esthesioneuroblastoma; histopathology; immunohistopathology; survival analysis; staging; grading;
D O I
10.1034/j.1600-0463.2002.1100907.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aims. To review all cases of esthesioneuroblastoma in Denmark from 1978 to 2000 with respect to staging, grading, histopathological and immunohistochemical evaluation, and prognostication. Methods and results. Possible cases of esthesioneuroblastoma were retrieved from Danish oncology departments. Patients were included on the basis of review of their files or pathology reports, and/or on the basis of histopathological and immunohistochemical examination. Forty-nine possible cases were retrieved. Nine cases were excluded. Esthesioneuroblastoma is a malignant neuroendocrine tumour originating in the olfactory mucosa. It is a small blue cell neoplasm with a characteristic lobular architecture. It has a neuroendocrine immunophenotype and a sustentacular S-100 staining pattern. The tumours were staged according to Kadish and graded according to Hyams. Kaplan-Meier survival analysis was used to identify prognostic factors. Conclusion. The Kadish staging system was able to group the patients into prognostically relevant groups. Intracranial involvement and metastases at the time of diagnosis were found to be poor prognostic factors. Hyams grading system is difficult to work with and it was not possible to divide patients into prognostically relevant groups. Presence of necrosis, a diffuse growth pattern and a high proliferation index proved to be equally poor prognostic factors.
引用
收藏
页码:639 / 645
页数:7
相关论文
共 26 条
[1]   Olfactory neuroblastoma is not related to the Ewing family of tumors -: Absence of EWS/FLI1 gene fusion and MIC2 expression [J].
Argani, P ;
Perez-Ordoñez, B ;
Xiao, H ;
Caruana, SM ;
Huvos, AG ;
Ladanyi, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (04) :391-398
[2]  
Berger L., 1924, Bull Assoc Fr Etude Cancer, V13, P410
[3]  
BILLER HF, 1990, LARYNGOSCOPE, V100, P1199
[4]  
Broich G, 1997, ANTICANCER RES, V17, P2683
[5]   ESTHESIONEUROBLASTOMA - THE UCLA EXPERIENCE 1970-1990 [J].
DULGUEROV, P ;
CALCATERRA, T .
LARYNGOSCOPE, 1992, 102 (08) :843-849
[6]  
ELKON D, 1979, CANCER, V44, P1087, DOI 10.1002/1097-0142(197909)44:3<1087::AID-CNCR2820440343>3.0.CO
[7]  
2-A
[8]  
Eriksen JG, 2000, ACTA ONCOL, V39, P231
[9]   SINONASAL UNDIFFERENTIATED CARCINOMA - AN AGGRESSIVE NEOPLASM DERIVED FROM SCHNEIDERIAN EPITHELIUM AND DISTINCT FROM OLFACTORY NEUROBLASTOMA [J].
FRIERSON, HF ;
MILLS, SE ;
FECHNER, RE ;
TAXY, JB ;
LEVINE, PA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1986, 10 (11) :771-779
[10]  
Hyams VJ, 1988, TUMORS UPPER RESP TR, P240